Matthew Burns

1.3k total citations · 1 hit paper
40 papers, 778 citations indexed

About

Matthew Burns is a scholar working on Oncology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matthew Burns has authored 40 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Neurology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matthew Burns's work include Myasthenia Gravis and Thymoma (9 papers), Mosquito-borne diseases and control (7 papers) and Malaria Research and Control (7 papers). Matthew Burns is often cited by papers focused on Myasthenia Gravis and Thymoma (9 papers), Mosquito-borne diseases and control (7 papers) and Malaria Research and Control (7 papers). Matthew Burns collaborates with scholars based in United States, Canada and United Kingdom. Matthew Burns's co-authors include P. J. Loehrer, Neville R. Pimstone, Patrick J. Loehrer, S.K. Mukerji, Philip J. Millar, Anthony V. Incognito, Anupama Kurup, William Pao, Constantin T. Yiannoutsos and E. Gabriela Chiorean and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthew Burns

39 papers receiving 755 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes

2022 108 citations Lalantha Leelarathna, Mark L. Evans et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Burns United States	17	267	260	136	109	96	40	778
Ashok Kumar India	15	158 0.6×	35 0.1×	101 0.7×	119 1.1×	191 2.0×	107	736
Maria Grazia Radaelli Italy	7	182 0.7×	70 0.3×	127 0.9×	203 1.9×	48 0.5×	8	734
Fengyu Lin China	14	86 0.3×	85 0.3×	58 0.4×	255 2.3×	20 0.2×	39	844
Zhaolong Cao China	5	32 0.1×	229 0.9×	52 0.4×	151 1.4×	36 0.4×	8	854
Peyman Nowrouzi‐Sohrabi Iran	10	71 0.3×	99 0.4×	66 0.5×	65 0.6×	20 0.2×	29	557
Bahman Razi Iran	16	59 0.2×	30 0.1×	93 0.7×	143 1.3×	49 0.5×	45	711
Ayşe Nur Torun Türkiye	11	119 0.4×	32 0.1×	41 0.3×	79 0.7×	34 0.4×	23	493
Qingyu Zhao China	10	78 0.3×	108 0.4×	47 0.3×	98 0.9×	37 0.4×	19	445

Countries citing papers authored by Matthew Burns

Since Specialization

Citations

This map shows the geographic impact of Matthew Burns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Burns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Burns more than expected).

Fields of papers citing papers by Matthew Burns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Burns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Burns. The network helps show where Matthew Burns may publish in the future.

Co-authorship network of co-authors of Matthew Burns

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Burns. A scholar is included among the top collaborators of Matthew Burns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Burns. Matthew Burns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burns, Matthew, et al.. (2024). Underserved farmers’ barriers to adoption of the U.S. Department of Agriculture Natural Resources Conservation Service climate-smart agricultural practices in South Carolina. SHILAP Revista de lepidopterología. 1–13. 2 indexed citations

Leelarathna, Lalantha, Chris Sutton, Mark L. Evans, et al.. (2023). Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH‐UK study. Diabetic Medicine. 41(3). e15249–e15249. 2 indexed citations

Elliott, Rachel, G Rogers, Mark L. Evans, et al.. (2023). Estimating the cost‐effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England. Diabetic Medicine. 41(3). e15232–e15232. 4 indexed citations

Wilmot, Emma G., Mark L. Evans, Katharine Barnard‐Kelly, et al.. (2021). Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol. BMJ Open. 11(7). e050713–e050713. 10 indexed citations

Larsen, David A., A. Martin, Carrie Nielsen, et al.. (2020). Leveraging risk maps of malaria vector abundance to guide control efforts reduces malaria incidence in Eastern Province, Zambia. Scientific Reports. 10(1). 10307–10307. 12 indexed citations

Hellyer, Jessica A., Matthew A. Gubens, Kristen Cunanan, et al.. (2019). Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies. Lung Cancer. 137. 71–75. 11 indexed citations

Burns, Matthew, et al.. (2018). Comparison of laboratory and ambulatory measures of central blood pressure and pulse wave reflection: hitting the target or missing the mark?. Journal of the American Society of Hypertension. 12(4). 275–284. 5 indexed citations

Gbolahan, Olumide B., et al.. (2018). A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma. Journal of Thoracic Oncology. 13(12). 1940–1948. 38 indexed citations

Incognito, Anthony V., Matthew Burns, Joshua T. Slysz, et al.. (2017). Muscle sympathetic nerve responses to passive and active one-legged cycling: insights into the contributions of central command. American Journal of Physiology-Heart and Circulatory Physiology. 314(1). H3–H10. 19 indexed citations

10.

Saski, Christopher, et al.. (2016). Transcriptome Profile of the Chicken Thrombocyte: New Implications as an Advanced Immune Effector Cell. PLoS ONE. 11(10). e0163890–e0163890. 20 indexed citations

11.

Wakelee, Heather A., Sukhmani K. Padda, Matthew Burns, et al.. (2015). Oral 1.01: Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies. Journal of Thoracic Disease. 7(3). 101. 1 indexed citations

12.

Larsen, David A., Matthew Burns, John M. Miller, et al.. (2015). Enhanced surveillance and data feedback loop associated with improved malaria data in Lusaka, Zambia. Malaria Journal. 14(1). 222–222. 22 indexed citations

13.

Gubens, Matthew A., et al.. (2015). A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies. Lung Cancer. 89(1). 57–60. 31 indexed citations

14.

Wakelee, Heather A., Sukhmani K. Padda, Matthew Burns, et al.. (2015). Phase II trial of single agent amrubicin (A) in patients (pts) with previously treated advanced thymic malignancies (TM).. Journal of Clinical Oncology. 33(15_suppl). 7580–7580. 5 indexed citations

15.

Khawaja, Muhammad Rizwan, Zhangsheng Yu, Howard Thomas, et al.. (2014). Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection. American Journal of Clinical Oncology. 40(1). 42–46. 3 indexed citations

16.

Chiorean, E. Gabriela, Sonal P. Sanghani, Menggang Yu, et al.. (2012). Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53. Cancer Chemotherapy and Pharmacology. 70(1). 25–32. 16 indexed citations

17.

McNulty, Dean E., Matthew Burns, Kimberly E. Allen, et al.. (2008). Frameshift events associated with the lysyl-tRNA and the rare arginine codon, AGA, in Escherichia coli: A case study involving the human Relaxin 2 protein. Protein Expression and Purification. 60(2). 110–116. 7 indexed citations

18.

Ezard, Nadine, Matthew Burns, Caroline A. Lynch, Qin Cheng, & Michael D. Edstein. (2003). Efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum infection in East Timor, 2000. Acta Tropica. 88(1). 87–90. 8 indexed citations

19.

Chen, Nanhua, Joanne Baker, Nadine Ezard, et al.. (2002). Short report: Molecular evaluation of the efficacy of chloroquine treatment of uncomplicated Plasmodium falciparum malaria in East Timor.. American Journal of Tropical Medicine and Hygiene. 67(1). 64–66. 10 indexed citations

20.

Collins, Rónán, et al.. (1999). Lambert-Eaton myasthenic syndrome in association with transitional cell carcinoma: a previously unrecognized association. Urology. 54(1). 162–162. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact